Dominique M. Elias

Dominique M. Elias's AcademicInfluence.com Rankings

Dominique M. Elias

Philosophy

#7178

World Rank

#10351

Historical Rank

Logic

#4247

World Rank

#5517

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Dominique M. Elias's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Dominique M. Elias Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dominique M. Elias's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. (2004) (1117)
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value (2013) (1044)
Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. (2010) (890)
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (2012) (808)
Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus (1997) (798)
Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. (2009) (791)
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. (1997) (655)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. (2009) (554)
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. (2008) (543)
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. (2006) (531)
Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy (2010) (479)
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin (1999) (462)
Adverse events during radiofrequency treatment of 582 hepatic tumors. (2003) (450)
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy (2001) (435)
Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases: Analysis of 1452 Patients and Development of a Prognostic Model (2006) (431)
Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy (2010) (425)
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. (2000) (396)
During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma (1999) (348)
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. (2002) (345)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement (2006) (339)
Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. (2005) (334)
Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. (2002) (308)
A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. (2018) (303)
Are G3 ENETS neuroendocrine neoplasms heterogeneous? (2013) (286)
Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect (2005) (263)
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. (2021) (255)
Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors (2002) (241)
Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases (2003) (236)
Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. (2010) (233)
Liver resection of colorectal metastases in elderly patients (2010) (226)
Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. (2005) (221)
Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. (2003) (219)
Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis (2011) (218)
Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy? (2013) (212)
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. (1998) (201)
Treatment of Peritoneal Carcinomatosis From Colorectal Cancer: Impact of Complete Cytoreductive Surgery and Difficulties in Conducting Randomized Trials (2004) (201)
Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. (2002) (194)
Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. (2005) (193)
Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT (2007) (192)
Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination (2008) (191)
Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. (1998) (186)
Preoperative portal vein embolization for extension of hepatectomy indications (1996) (181)
Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure (2007) (181)
Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. (1993) (179)
Extent of Colorectal Peritoneal Carcinomatosis: Attempt to Define a Threshold Above Which HIPEC Does Not Offer Survival Benefit: A Comparative Study (2015) (179)
Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy (2002) (177)
Peritoneal carcinomatosis of colorectal origin. (2006) (173)
Results of R0 Resection for Colorectal Liver Metastases Associated With Extrahepatic Disease (2004) (172)
Hepatic Metastases From Neuroendocrine Tumors With a “Thin Slice” Pathological Examination: They are Many More Than You Think … (2010) (172)
Transcatheter chemoembolization of progressive carcinoid liver metastasis. (1993) (170)
Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients (2014) (169)
An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. (2003) (167)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. (2007) (165)
Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis (2011) (160)
Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases (1998) (154)
Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. (2002) (153)
A Comparative Study of Complete Cytoreductive Surgery Plus Intraperitoneal Chemotherapy to Treat Peritoneal Dissemination From Colon, Rectum, Small Bowel, and Nonpseudomyxoma Appendix (2010) (152)
Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. (1992) (151)
Results of Systematic Second-Look Surgery in Patients at High Risk of Developing Colorectal Peritoneal Carcinomatosis (2008) (149)
Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. (2014) (143)
Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43°C After Compete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients (2007) (143)
Definition of Patients Presenting a High Risk of Developing Peritoneal Carcinomatosis After Curative Surgery for Colorectal Cancer: A Systematic Review (2012) (141)
A novel tumor‐node‐metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi‐institutional database * (2011) (140)
Local Recurrences After Intraoperative Radiofrequency Ablation of Liver Metastases: A Comparative Study with Anatomic and Wedge Resections (2004) (139)
Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases (2005) (138)
Surgical management of primary anorectal melanoma (2004) (136)
Hepatic Resection for Metastatic Melanoma: Distinct Patterns of Recurrence and Prognosis for Ocular Versus Cutaneous Disease (2006) (134)
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? (2004) (134)
Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. (1995) (134)
Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. (2006) (133)
Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis (2007) (132)
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. (2004) (130)
Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. (1998) (129)
Outcome of Posthepatectomy-Missing Colorectal Liver Metastases after Complete Response to Chemotherapy: Impact of Adjuvant Intra-arterial Hepatic Oxaliplatin (2007) (126)
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (2008) (124)
Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. (2001) (122)
Preoperative portal vein embolization for extension of hepatectomy indications. (1996) (122)
Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases (2010) (121)
Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making. (1992) (120)
Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. (2000) (119)
Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. (2000) (118)
Predictive Factors for Hypertrophy of the Future Remnant Liver After Selective Portal Vein Embolization (2010) (117)
Quality of Life of Patients Operated on for Low Rectal Cancer: Impact of the Type of Surgery and Patients’ Characteristics (2005) (117)
[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]. (1999) (116)
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis. (1994) (115)
Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer (2015) (113)
Prolonged intermittent clamping of the portal triad during hepatectomy (1991) (113)
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma. (2009) (112)
Liver abscess formation after local treatment of liver tumors (1996) (111)
How I Do It: Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection (1998) (109)
Transanal Endoscopic Total Mesorectal Excision Combined With Single-Port Laparoscopy (2012) (100)
Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy (2004) (100)
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials. (2015) (100)
Human Pharmacokinetic Study of Heated Intraperitoneal Oxaliplatin in Increasingly Hypotonic Solutions after Complete Resection of Peritoneal Carcinomatosis (2002) (100)
Repeat hepatectomy for cancer (1993) (99)
Is simultaneous hepatectomy and intestinal anastomosis safe? (1995) (99)
Self-expanding metallic stents as palliative treatment of malignant gastroduodenal stenosis. (1997) (98)
Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. (2004) (96)
GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs. (2015) (96)
Impact of chromogranin A measurement in the work-up of neuroendocrine tumors. (2001) (96)
Preoperative assessment of resectability of hepatic metastases from colonic carcinoma: CT portography vs sonography and dynamic CT. (1992) (94)
Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging. (2011) (94)
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study. (2020) (92)
Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. (2004) (91)
Should Patients With Peritoneal Carcinomatosis of Colorectal Origin With Synchronous Liver Metastases Be Treated With a Curative Intent? A Case-Control Study (2013) (91)
Intermittent vascular exclusion of the liver (without vena cava clamping) during major hepatectomy (1995) (91)
Combination Chemotherapy in Advanced Small Bowel Adenocarcinoma (2005) (90)
The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. (2005) (90)
Preoperative segmental localization of hepatic metastases: utility of three-dimensional CT during arterial portography. (1991) (88)
Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. (2003) (88)
A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. (2016) (87)
MRI of Liver Metastases from Colorectal Cancer vs. CT during Arterial Portography (1993) (84)
Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. (2005) (82)
Hepatectomy for liver metastases from breast cancer. (1995) (81)
Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. (1991) (81)
Peritoneal Cystic Mesothelioma: A Case Series (2003) (81)
Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. (2014) (81)
Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. (2010) (79)
Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study. (2010) (79)
Fibrin glue effectiveness and tolerance after elective liver resection: a randomized trial. (1996) (78)
Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. (1994) (76)
Intraductal cooling of the main bile ducts during radiofrequency ablation prevents biliary stenosis. (2004) (76)
Bevacizumab Doubles the Early Postoperative Complication Rate after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis of Colorectal Origin (2013) (74)
Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases (1996) (73)
Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion. (2008) (72)
[Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy]. (2008) (72)
Adjuvant Chemotherapy After Resection of Colorectal Liver Metastases in Patients at High Risk of Hepatic Recurrence: A Comparative Study Between Hepatic Arterial Infusion of Oxaliplatin and Modern Systemic Chemotherapy (2013) (71)
Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas (2018) (71)
Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers. (2015) (71)
Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study. (2016) (71)
Incidence of Unsuspected and Treatable Metastatic Disease Associated With Operable Colorectal Liver Metastases Discovered Only at Laparotomy (and Not Treated When Performing Percutaneous Radiofrequency Ablation) (2005) (71)
Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas. (2005) (69)
A UNICANCER phase III trial of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Carcinomatosis. PRODIGE 7. (2019) (69)
Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394). (2018) (68)
Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure. (2006) (68)
Progression while Receiving Preoperative Chemotherapy Should Not Be an Absolute Contraindication to Liver Resection for Colorectal Metastases (2012) (67)
Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei (2014) (66)
The differential response to chemotherapy of ovarian metastases from colorectal carcinoma. (2008) (65)
Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver. (2009) (65)
Percutaneous femoral implantation of an arterial port catheter for intraarterial chemotherapy: feasibility and predictive factors of long-term functionality. (2010) (63)
Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. (2007) (62)
Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts. (1994) (62)
Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer (2016) (60)
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. (2005) (60)
Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings. (2008) (59)
Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases). (2014) (59)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement (2007) (58)
Multimodality treatment of patients with liver metastases from germ cell tumors (2001) (58)
Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma. (2010) (57)
Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG‐RENAPE) (2018) (56)
Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver. (1998) (55)
Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. (2004) (54)
A Simple Tumor Load-Based Nomogram for Surgery in Patients with Colorectal Liver and Peritoneal Metastases (2014) (54)
Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies. (2006) (54)
Prognostic factors for chemoembolization in liver metastasis from endocrine tumors. (2004) (52)
Two-Stage Hepatectomy Versus 1-Stage Resection Combined With Radiofrequency for Bilobar Colorectal Metastases: A Case-Matched Analysis of Surgical and Oncological Outcomes (2014) (52)
[Digestive oncology: surgical practices]. (2009) (52)
Preoperative chemotherapy of locally advanced gastric cancer. (1994) (51)
Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? (2017) (51)
Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi‐center data analysis using LiverMetSurvey (2015) (48)
Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis? (2010) (47)
Surgical approach to segment I for malignant tumors of the liver. (1992) (46)
Importance of gender in diffuse malignant peritoneal mesothelioma. (2012) (46)
Long-term outcomes of patients with 10 or more colorectal liver metastases (2017) (45)
Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy. (2008) (45)
Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab (2014) (44)
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors (2016) (44)
Treatment and prevention of peritoneal carcinomatosis from colorectal cancer. (2003) (44)
Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study (2016) (44)
Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis (2005) (43)
Pseudocontinent perineal colostomy following abdominoperineal resection: technique and findings in 49 patients. (2001) (43)
Antiangiogenic agents and late anastomotic complications (2010) (43)
Surgical treatment of hepatic metastases: impact of intraoperative sonography. (1993) (42)
Intra-Arterial Hepatic Chemotherapy: A Comparison of Percutaneous Versus Surgical Implantation of Port-Catheters (2011) (42)
Thyroid metastases from colorectal cancer: the Institut Gustave Roussy experience. (2006) (41)
[Tumor implantation in cicatrization sites following surgery for digestive cancers]. (1996) (40)
Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC) (2014) (40)
Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin (2004) (38)
[Surgical treatment of peritoneal carcinomatosis]. (2004) (38)
The Second Procedure Combining Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy for Isolated Peritoneal Recurrence: Postoperative Course and Long-Term Outcome (2009) (37)
Prognostic value of neural invasion in rectal carcinoma: a multivariate analysis on 339 patients with curative resection. (1995) (37)
Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma. (2012) (37)
Peritoneal carcinomatosis from solid pseudopapillary neoplasm (Frantz's tumour) of the pancreas treated with HIPEC. (2012) (37)
Variation in the peritoneal cancer index scores between surgeons and according to when they are determined (before or after cytoreductive surgery). (2012) (36)
Functional results and quality of life for patients with very low rectal cancer undergoing coloanal anastomosis or perineal colostomy with colonic muscular graft. (2007) (36)
Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix. (2015) (36)
Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients. (2017) (35)
Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study. (2013) (35)
Recurrence of Solid Pseudopapillary Neoplasms of the Pancreas: Results of a Nationwide Study of Risk Factors and Treatment Modalities (2016) (34)
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience (2018) (34)
Comparison of fecal continence and quality of life between intersphincteric resection and abdominoperineal resection plus perineal colostomy for ultra‐low rectal cancer (2013) (34)
Ex Vivo Sentinel Lymph Node Study For Rectal Adenocarcinoma: Preliminary Study (2005) (34)
Complete Radiological Response of Colorectal Liver Metastases after Chemotherapy: What Can We Expect? (2011) (34)
Potent immunomodulatory effects of the trifunctional antibody catumaxomab. (2013) (33)
Accelerated fractionation in esophageal cancers: a multivariate analysis on 88 patients. (1997) (33)
Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei. (2019) (33)
Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients. (2013) (33)
Patients Operated On for Initially Unresectable Colorectal Liver Metastases With Missing Metastases Experience a Favorable Long-Term Outcome (2011) (33)
Incidence, distribution, and significance of hilar lymph node metastases in hepatic colorectal metastases. (2003) (32)
Comparison of Complete Pathologic Response and Hepatic Injuries Between Hepatic Arterial Infusion and Systemic Administration of Oxaliplatin in Patients with Colorectal Liver Metastases (2014) (32)
Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1 (2018) (32)
HIPEC for Peritoneal Carcinomatosis: Does an Associated Urologic Procedure Increase Morbidity? (2011) (30)
Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer. (2008) (30)
Peritoneal carcinomatosis treatment with curative intent: the Institut Gustave-Roussy experience. (1997) (30)
Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey. (2015) (29)
Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy (2017) (29)
Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases--a pilot study. (1987) (29)
Biliary Lesions during Radiofrequency Ablation in Liver (2004) (29)
Peritoneal carcinomatosis of colorectal origin Long-term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery (2006) (28)
[Long-term oncological results of hepatectomy performed after selective portal embolization]. (1999) (27)
Preoperative criteria of incomplete resectability of peritoneal carcinomatosis from non-appendiceal colorectal carcinoma. (2005) (27)
The trans‐metastasis hepatectomy (through metastases previously ablated with radiofrequency): Results of a 13‐case study of colorectal cancer (2006) (27)
Oncologic and Functional Results After Abdominoperineal Resection Plus Pseudocontinent Perineal Colostomy for Epidermoid Carcinoma of the Anus (2009) (27)
Usefulness of Guiding Needles for Radiofrequency Ablative Treatment of Liver Tumors (2006) (27)
Resection of Rectal Cancer via an Abdominal Single-Port Access: Short-term Results and Comparison With Standard Laparoscopy (2013) (27)
Prenatal diagnosis of fetal bilateral adrenal carcinoma (2005) (26)
New Perspectives in the Treatment of Colorectal Metastases (2016) (26)
Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy? (2016) (25)
A Phase II Study of Irinotecan with 5-Fluorouracil and Leucovorin in Patients with Pretreated Gastroenteropancreatic Well-Differentiated Endocrine Carcinomas (2006) (25)
[Pseudo-continent perineal colostomies after amputation of the rectum for cancer]. (1993) (25)
Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy. (1991) (24)
HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. (2007) (24)
Sentinel lymph nodes of colorectal carcinoma: reappraisal of 123 cases. (2007) (23)
Regional chemotherapeutic techniques for liver tumors: current knowledge and future directions. (2004) (23)
Intermittent complete vascular exclusion of the liver during hepatectomy: technique and indications. (1998) (23)
Central retroperitoneal recurrences from colorectal cancer: are lymph node and locoregional recurrences the same disease? (2012) (23)
The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy. (2013) (23)
Prevention of Biliary Lesions That May Occur During Radiofrequency Ablation of the Liver: Study on the Pig (2006) (23)
Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei. (2017) (22)
Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art. (2015) (22)
Intra‐Arterial Hepatic Chemotherapy with Pirarubicin: Preclinical and Clinical Studies (1990) (22)
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry (2018) (22)
[Peritoneal carcinosis treated by complete excision and immediate postoperative intra-peritoneal chemotherapy. Phase II study in 54 patients]. (1997) (22)
Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers. (2013) (21)
"Natural history" of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. (2009) (21)
Peritoneal Carcinomatosis or Liver Metastases from Colorectal Cancer: Similar Standards for a Curative Surgery? (2004) (21)
The long-term impact of hyperthermic intraperitoneal chemotherapy on survivors treated for peritoneal carcinomatosis: a cross-sectional study (2009) (20)
[Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience]. (1999) (20)
Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer? (2017) (20)
Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy. (2014) (19)
Can a Benefit be Expected from Surgical Debulking of Unresectable Pseudomyxoma Peritonei? (2016) (19)
Early and long-term outcome data on 2,298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (2012) (18)
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC. (2017) (18)
Hepatic arterial infusion (HAI) of oxaliplatin plus intravenous (iv) fluorouracil (FU), leucovorin (LV), and cetuximab for first-line treatment of unresectable colorectal liver metastases (CRLM) (CHOICE): A multicenter phase II study. (2010) (18)
Impact on survival of primary tumor resection in patients with colorectal cancer and unresectable metastasis: Pooled analysis of individual patients' data from four randomized trials. (2012) (18)
Hepatocellular Carcinoma During Hormonotherapy for Prostatic Cancer (1994) (18)
[Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase I-II study defining the best technical procedures]. (1999) (17)
Huge pseudomyxoma peritonei: Surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery. (2016) (17)
Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives? (2017) (17)
[Primary anorectal melanoma. Apropos of 19 cases]. (1997) (17)
Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect? (2018) (16)
Therapeutic Strategies for Advanced Pancreatic Neuroendocrine Tumors with Segmental Portal Hypertension (2015) (16)
Mutational status of EGFR, BRAF, PI3KCA and JAK2 genes in endocrine tumors (2009) (16)
A simplified surgical technical procedure for intra-arterial chemotherapy in secondary liver cancer. Experience in 50 patients. (1987) (16)
Intervention in gastro-enteropancreatic neuroendocrine tumours. (2012) (15)
Pancreatic cancer: From pathogenesis to cure (2007) (15)
[Cancers of the rectum: predictive factors in locoregional recurrence. Multifactorial study]. (1985) (15)
Preoperative Portal Vein Embolization Tailored to Prepare the Liver for Complex Resections: Initial Experience (2010) (15)
T‐cell receptor CDR3 size distribution analysis to evaluate specific T‐cell response to cancer vaccines (1997) (15)
Ovarian Metastasis Is Associated with Retroperitoneal Lymph Node Relapses in Women Treated for Colorectal Peritoneal Carcinomatosis (2013) (14)
[Induction of hypertrophy of a small left hepatic lobe by preoperative right portal embolization, preceding extended right hepatectomy]. (1992) (14)
Comparison Between the Minimum Margin Defined on Preoperative Imaging and the Final Surgical Margin After Hepatectomy for Cancer: How to Manage It? (2008) (14)
Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia in Patients With Colorectal Cancer at High Risk for Local-Regional Recurrence (2009) (14)
Value of cardiophrenic angle lymph node for the diagnosis of colorectal peritoneal carcinomatosis. (2013) (14)
Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues. (1993) (14)
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973) (2018) (14)
[Salvage surgery for anal canal carcinomas]. (2004) (14)
Circumferential pharyngolaryngectomy with total esophagectomy for locally advanced carcinomas (1998) (13)
Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastases. (1994) (13)
[Hepatectomy for hepatocarcinoma on a cirrhotic liver: decision plans and principles of perioperative resuscitation. Experience with 204 cases]. (1987) (13)
Interventional revisions of malfunctions affecting surgically implanted port-catheters for hepatic artery infusion. (2013) (13)
Cytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nationwide study over 14 years (2018) (13)
Options and outcome for reconstruction after extended left hemicolectomy (2013) (13)
A pre‐operative nomogram for decision making in oncological surgical emergencies (2014) (13)
A New Policy Regarding Ovarian Resection in Young Women Treated for Peritoneal Carcinomatosis (2013) (12)
Carcinomas of the colon with multidirectional differentiation (2005) (12)
Sarcoidosis and Testicular Germ Cell Tumor (1990) (11)
[Resectable liver metastases and synchronous extra-hepatic sites of colorectal origin. Surgical indications]. (1993) (11)
Transmetastasis curative liver resection immediately following radiofrequency destruction (2002) (11)
Trans-metastasis hepatectomy: results of a 21-case study. (2006) (11)
Reflections and proposals for the standardization of lymphadenectomy for gastric carcinoma. (2000) (11)
[Impact of tumor doubling time on the therapeutic strategy: application to so-called synchronous metastases of colorectal cancers]. (1998) (11)
[Is the aggressive treatment of locoregional recurrences of colorectal cancers justified?]. (1991) (11)
Cost of radiofrequency ablation in the treatment of hepatic malignancies. (2007) (11)
Surgical strategy for low rectal cancers. (2015) (11)
Impact of perineal pseudocontinent colostomy on perineal wound healing after abdominoperineal resection (2012) (11)
Resection of liver metastases from non-colorectal non-endocrine primary tumours. (2008) (11)
Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer. (2017) (11)
[Cost of an intraperitoneal chemohyperthermia (IPCH) related to cytoreductive surgery]. (2005) (11)
[Anatomo-pathologic study of hepatic toxicity in intra-arterial hepatic chemotherapy]. (1989) (10)
Transpleurodiaphragmatic radiofrequency thermoablation of a liver metastasis. (2000) (10)
Comprehensive study of ovarian metastases in young women with peritoneal pseudomyxoma: is a preservation of fertility possible? (2013) (10)
Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases (2019) (10)
[Synchronous cancers of the esophagus and of the ORL area: results of combined treatments with esophagectomy (28 cases)]. (1991) (10)
Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study (2016) (10)
Abdominoperineal resection combined with pre- and postoperative radiation therapy in the treatment of low-lying rectal carcinoma. (1997) (9)
Catheter placement for intra-arterial hepatic chemotherapy. (2012) (9)
Autologous peritoneo-fascial graft: a technique for vascular reconstruction. (2014) (9)
[Perioperative autotransfusion with salvage blood in cancer surgery] . (2000) (9)
Second-look surgery plus HIPEC for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Should we resect the initial anastomosis? An observational study. (2015) (9)
[Intraperitoneal hyperthermic chemotherapy (IPHC), a promising treatment of peritoneal carcinomatosis]. (1994) (9)
An appendix carcinoid tumor in a patient with hereditary nonpolyposis colorectal cancer. (2004) (9)
Surgical treatment of severe late radiation injury to the bowel: a retrospective analysis of 83 cases. (2002) (9)
Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy. (2013) (9)
[Another failure in the attempt of definition of the indications to the resection of liver metastases of colorectal origin]. (1992) (9)
Computed Tomographic Features of Peritoneal Carcinomatosis Treated by Intraperitoneal Chemohyperthermia (2003) (9)
Postoperative Peritonitis Without An Underlying Digestive Fistula After Complete Cytoreductive Surgery Plus HIPEC (2013) (9)
[Repercussions of surgery effecting tumor growth]. (1990) (8)
Gastric linitis adenocarcinoma and carcinomatous meningitis: an infrequent but aggressive association--report of four cases. (2001) (8)
[A multivariate prospective study of prognostic factors in 200 operated epidermoid cancers of the esophagus. Definition of patients for whom surgical resection was of benefit]. (1993) (8)
Incidence and prognosis of synchronous colorectal carcinomatosis. (2013) (8)
Results of lymphadenectomy for obvious lateroaortic lymph node metastases from colorectal primaries. (2001) (8)
[Neuro-endocrine tumors and von Hippel-Lindau disease. 3 cases]. (1999) (8)
[Role of imaging in abdominopelvic follow-up after resection of colorectal cancer]. (1997) (8)
Pelvectomie totale et cancer du rectum. À propos de 20 observations (1999) (8)
Surgery for liver metastases from breast cancer. (2006) (8)
[Blood transfusions in cancer patients]. (1996) (8)
[Treatment of desmoid tumors of the mesenteric root]. (2000) (8)
[Pseudo-continent perineal colostomy. Results and techniques]. (1997) (8)
CHIMIOTHERAPIE INTRA-ARTERIELLE HEPATIQUE. EXPERIENCE DE 200 CAS (1994) (8)
[Epidermoid epitheliomas of the rectum : a report on three cases (author's transl)]. (1980) (7)
Reflections and proposals for the worldwide standardization of lymphadenectomy for gastric carcinoma (1999) (7)
Use of the Cell Saver in Oncologic Surgery (2001) (7)
High response rates with isolated pelvic perfusion (IPP) with a pneumatic anti-shock garments (PASG) and low-dose TNF-α for locally advanced pelvic sarcomas and carcinomas: A phase II unicenter trial (2008) (7)
The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure. (2007) (7)
Placement of an arterial hepatic catheter after a major hepatectomy for colorectal liver metastases: is this safe? (2013) (7)
Systemic and local chemotherapy in palliative and adjuvant treatment of hepatic metastases of colorectal origin (1992) (7)
Intra-arterial hepatic chemotherapy for metastatic liver from colo-rectal carcinoma origin. (1989) (7)
[Epidermoid cancers of the operated esophagus. High incidence of associated neoplasia]. (1992) (6)
[Gastric adenocarcinoma surgically treated. A multivariate analysis of prognostic factors]. (1988) (6)
[Single and multifactorial prognostic study of 400 operated rectal adenocarcinomas]. (1993) (6)
Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Peritoneal Carcinomatosis of Digestive and Peritoneal Origin: Rationale (2006) (6)
Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases (2019) (6)
Challenging and unusual cases: Case 3. Peritoneal cystic mesothelioma. (2003) (6)
Thermic homogeneity and standardization of intraperitoneal chemohyperthermia for peritoneal carcinomatosis (1996) (6)
[Complications and tolerance of heated intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis: results of a phase I-II study of peritoneal carcinomatosis from different sources]. (2000) (6)
[Complete (R0) resection is the only valid prognostic factor in abdominoperineal resection for recurrent cancer of the anal canal (a consecutive series of 95 patients)]. (2008) (6)
[Cutaneous metastasis disclosing adrenal cortical carcinoma]. (1994) (6)
[Is sentinel lymph node mapping relevant for colon cancer?: a feasibility study]. (2003) (6)
[Control of perfusion by angioscintigraphy during hepatic intra-arterial chemotherapy]. (1989) (6)
Hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for the treatment of peritoneal carcinomatosis in pediatric solid malignancies: a single institution experience. (2014) (6)
[Indications and surgical technique of Appleby's operation for tumor invasion of the celiac trunk and its branches]. (2009) (5)
[Gastroduodenal complications of hepatic intra-arterial chemotherapy of hepatic metastases of colorectal origin]. (1989) (5)
Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy (2005) (5)
[Radiofrequency: storm looming over hepatic surgery]. (2000) (5)
[Treatment of malignant gastric or duodenal stenoses by the insertion of metallic prostheses under fluoroscopic control]. (1998) (5)
Laparoscopic single port pseudo-continent perineal colostomy. (2016) (5)
Erratum: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement (Annals of Surgical Oncology 14 (128-133)DOI: 10.1245/s10434-006-9185-7) (2011) (5)
[What are the real indications for hepatectomies in metastases of colorectal origin?]. (1998) (5)
Selection for hepatic resection: expert consensus conference. (2013) (5)
[Radiofrequency for the treatment of liver tumors]. (2001) (5)
Two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC following complete cytoreductive surgery for colorectal carcinomatosis. (2011) (5)
Esophageal squamous cell carcinoma: the specific limited place of surgery defined by a prospective multivariate study of prognostic factors after surgical approach. (1992) (5)
Mid-Term Audit of a National Peritoneal Surface Malignancy Program Implementation in a Low Middle Income Country: The Moroccan Experience (2021) (5)
[Treatment of epidermoid cancer of the esophagus]. (1984) (5)
[Treat the peritoneum with respect! It's our first line of defense against carcinomatosis]. (2007) (4)
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from digestive or primitive origin: A multi-institutional study of 1,290 patients. (2009) (4)
Single-step balloon dilation of postoperative pyloric stenosis: benefit of large-balloon technique. (1994) (4)
P1-123: Response of atypical pulmonary carcinoid tumors to chemotherapy. A retrospective study of 37 patients. (2007) (4)
[Surgery called tumoral reduction: myth or reality?]. (1992) (4)
[Locating parathyroid glands by methylene blue during thyroid surgery]. (1983) (4)
[Treatment of peritoneal carcinosis of colorectal origin]. (1997) (4)
[Total pelvic exenteration and rectal cancer. Apropos of 20 cases]. (1999) (4)
Peritoneal carcinomatosis of colorectal origin: recent advances and future evolution toward a curative treatment. (2007) (4)
[Resectional treatment of peritoneal carcinomatosis followed by intraperitoneal chemotherapy, practical aspects]. (2003) (4)
[Immediate intraperitoneal chemotherapy after surgery for the reduction of peritoneal malignancies: for what purpose and for whom?]. (1995) (4)
Acute Pancreatitis Following Segmental Pancreatic Resection Associated with Portal Vein Thrombosis and Aneurysm of the Spleno-Mesenteric Venous Confluence (2007) (4)
Abdominal surgical emergencies in patients with advanced cancer. (2015) (4)
Neoadjuvant chemotherapy (NCT) in locally advanced gastric carcinoma (LAGC) (1993) (3)
Strategies for resection using portal vein embolization: metastatic liver cancer. (2008) (3)
[Technics of extensive lymph node curettage in cancer of the esophagus]. (1989) (3)
Surgical management of gastrointestinal stromal tumors (GIST) (1999) (3)
Use of a breast implant in 12 patients to prevent small-bowel injury in high postoperative irradiation for pelvic cancers (1987) (3)
[Value of endorectal ultrasonography in the treatment of rectal tumors]. (1996) (3)
[Simplified technic of implanting a catheter in a case of single right hepatic artery]. (1988) (3)
[Rational of oncological surgery in multimodality treatment of cancers]. (2006) (3)
[Surgical treatment of peritoneal carcinomatosis]. (2004) (3)
[Treatment of hepatocellular carcinoma in the presence of liver cirrhosis]. (1995) (3)
[Leiomyosarcoma of the suprarenal inferior vena cava. Chemotherapy and renorenal venous surgical anastomosis for the preservation of the right kidney]. (1983) (3)
Results of a phase II randomized study evaluating the potential benefit of a postoperative intraperitoneal immunotherapy after resection of peritoneal metastases from gastric carcinoma metastases (IIPOP- NCT01784900). (2017) (3)
Subtotal colectomy by single-incision laparoscopy for familial adenomatous polyposis. (2012) (3)
[Pelvic cancers: radioprotection of the small intestine by using a mammary prosthesis for postoperative irradiation. Apropos of 12 cases]. (1986) (3)
Sarcoidosis and testicular germ cell tumor. Case report. (1990) (3)
[Expert agreement on the minimal descriptive surgical report for peritoneal cancer]. (2007) (2)
Reply to letter: "Prevention of peritoneal carcinomatosis from colorectal cancer: a critical issue". (2014) (2)
[Surgical interventions for erroneous diagnoses of liver metastases]. (1994) (2)
[Peroperative ultrasonics and hepatic metastases]. (1985) (2)
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]. (1999) (2)
Prise en charge de l’abdomen chirurgical des patients neutropéniques : à propos de 21 observations (2001) (2)
Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry study. (1990) (2)
A Phase 3 Randomised Study Evaluating the Benefit of Second-Look Surgery Plus HIPEC in Patients at High Risk of Developing Colorectal Peritoneal Metastases (PROPHYLOCHIP) (2020) (2)
[Surgical approaches to segment I for malignant tumors (20 cases)]. (1993) (2)
[Retrospective study of 88 cases of cancer of the cervical esophagus and definition of a new therapeutic approach]. (1983) (2)
Is Intraperitoneal Chemotherapy After Cytoreductive Surgery Efficient? Knowing Whether It Is or Not Appears Secondary! (2012) (2)
Intraperitoneal chemotherapy (IPC) after complete resection of peritoneal sarcomatosis (PS): Results of a monocentric randomized study (2001) (2)
[Desmoid tumors or intra-abdominal fibromatoses]. (1993) (2)
[Contributions and limitations of transcutaneous ultrasonography in the preoperative evaluation for hepatic resections]. (1994) (2)
Simple criteria to predict margin involvement after chemoradiotherapy and sphincter-sparing for low rectal cancer. (2015) (2)
[Hepatic metastases of colorectal cancers: intra-arterial chemotherapy. Value and indications]. (1996) (2)
[Diagnosis and treatment of peritoneal carcinoma]. (2004) (2)
Breast cancer liver metastases (BCLM): What may be the role of surgery combined with chemotherapy? (2007) (2)
[Major hepatectomy after intra-arterial chemotherapy for initially unresectable liver tumors. Frequency, technical problems, results and indications]. (1996) (2)
Influence of bevacizumab on early postoperative complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin. (2012) (1)
Surgical management of primary and recurrent soft tissue sarcomas of the retroperitoneum (1997) (1)
Abstract No. 76: Intra-arterial hepatic chemotherapy: A comparison of percutaneous versus surgical implantation of port catheters (2010) (1)
[Preoperative portal embolization: an effective means for inducing hypertrophy of the healthy liver and increasing indications for hepatic resection]. (1998) (1)
Peritoneal metastases and peritoneal mesothelioma (2015) (1)
98. Perioperative outcomes of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal carcinomatosis: PRODIGE 7 randomized trial (2016) (1)
[Importance of a multidisciplinary approach to metastatic cancer of the rectum]. (1998) (1)
[Basic concepts and future prospects of oncologic surgery]. (1997) (1)
Value of cardiophrenic angle lymph nodes for the diagnosis of colorectal peritoneal carcinomatosis. (2013) (1)
Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with curative intent? A case-control study. (2012) (1)
Adjuvant HIPEC in Colorectal Cancer (2014) (1)
Cerebrovascular accident associated with chemotherapy for oesophageal carcinoma. (1992) (1)
[Rational bases and results of intra-arterial hepatic chemotherapy]. (1988) (1)
Principles of Hepatic Surgery (2016) (1)
[Isolated hepatic metastases. Treatment by intra-arterial chemotherapy using a subcutaneous access chamber]. (1986) (1)
[Surgical technique of extended lymph node excision (type R2 and R3) in gastric adenocarcinomas]. (1995) (1)
[Surgical treatment of severe radiation injuries of the small intestine and colon-rectum. Apropos of 85 patients surgically-treated at the Gustave-Roussy Institute]. (1985) (1)
[Triple hepatectomy for cancer]. (1993) (1)
[Modified duodenal diversion in the treatment of esophagitis from bile reflux complicating an upper-pole gastrectomy]. (1983) (1)
Phase II study of 4'epirubicin in advanced squamous cell oesophageal cancer. (1994) (1)
Bevacizumab plus chemotherapy (bev/CT) as first-line therapy for patients with potentially resectable metastatic colorectal cancer (mCRC): Final results of the French noninterventional PICASSO study. (2016) (1)
Multimodality treatment combining chemotherapy, liver surgery, peritoneal resection and hyperthermic intraperitoneal chemotherapy (HIPEC) for metastatic colorectal cancer (mCRC) patients with synchronous liver metastases (LM) and peritoneal carcinomatosis (2013) (1)
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]. (1999) (1)
[The medical and surgical management of acute abdominal complications in neutropenic cancer patient: description of 21 cases]. (2001) (1)
[Epidermoid cancers of the esophagus: combined chemotherapy, surgery and radiotherapy. Preliminary results in 50 cases]. (1988) (1)
[Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma. Preliminary results]. (1989) (1)
[Rectal adenocarcinoma in adults under 35 years of age. Apropos of 37 cases]. (1984) (1)
[Linitis of the colon with peritoneal carcinosis treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy]. (2007) (1)
Hepatic resection of initially unresectable liver metastases from colorectal cancer after hepatic arterial infusion of oxaliplatin and systemic 5-fluorouracil and leucovorin. (2009) (1)
Can patients be cured after cytoreductive surgery plus intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis? (2011) (1)
[Treatment of a phytobezoar with PEG 4000]. (1992) (1)
Treatment of pancreatic endocrine tumours with adriamycine-streptozotocin association: evaluation of efficacy and prognostic factors of response and survival (2001) (0)
Pursuing the NED condition in stage IV colorectal cancer (2012) (0)
[Prevention of radiolesions of the small intestine by intrapelvic silicone breast prosthesis]. (1985) (0)
Iconographies supplémentaires de l'article : A prolonged follow-up provides new insights into locally advanced pancreatic cancer treatment (2008) (0)
Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab (2014) (0)
[Surgery of hepatocellular carcinoma in cirrhosis. Update of decision elements and current perspectives]. (1987) (0)
Does systemic chemotherapy prior to surgery increase the operative risk of a major hepatectomy (2001) (0)
RESULTSOFLARGEABDOMINAL WALLRESECTIONREPAIREDWITHBIOMATERIAL DURINGHIPECFOLLOWINGCYTOREDUCTIVE SURGERYFORPERITONEALMETASTASES (2014) (0)
RESULTSOFLARGEABDOMINAL WALLRESECTIONREPAIREDWITHBIOMATERIAL DURINGHIPECFOLLOWINGCYTOREDUCTIVE SURGERYFORPERITONEALMETASTASES (2014) (0)
[Proctectomy for cancer]. (1994) (0)
[Management of disclosed hepatic metastases]. (1996) (0)
[Evaluation of 242 laparotomies for hepatic metastasis performed at the Institut Gustave Roussy over 5 years]. (1988) (0)
Portal Vein Embolization (2020) (0)
[Total esophagoplasty using a double pedicled free graft from the jejunum: the last resort]. (1994) (0)
Colostomie périnéale pseudocontinente par cœlioscopie single port (2016) (0)
[Colorectal cancer with synchronous liver metastases: is it always necessary to resect primary tumor?]. (2002) (0)
Drug combinations for hipec after cytoreductive surgery in diffuse malignant peritoneal mesothelioma: A PSOGI registry study (2018) (0)
Multidisciplinary management of rectal cancer with synchronous metastasis (1998) (0)
Stability assessment of CPT11 and LOHP in hyperthermic intraperitoneal chemotherapy (2001) (0)
P-0025 Modified Folfiri (mFolfiri) as Second Line Chemotherapy in Advanced Gastric Cancer (AGC) (2012) (0)
Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas (2018) (0)
[Rectal cancer and quality of life: what is known and what it means to tailor the treatment to patients]. (2005) (0)
Bevacizumab before cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin: Analysis of early postoperative complication rate and long term follow-up. (2013) (0)
Volumetric Modifications of Metastatic Liver Volumes after Dramatic Responses under Chemotherapy (2012) (0)
Hepatic Resection for Extrahepatic Metastatic Disease: When Is It Reasonable? (2015) (0)
Role of aggressive surgery for peritoneal metastases (2013) (0)
[Antineoplastic therapy and perioperative period in oncologic surgery]. (1996) (0)
[Cancer of the cervical esophagus. 64 cases treated by radiotherapy. Evaluation and considerations]. (1983) (0)
Treatment of liver metastases and moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate postoperative chemotherapy: Feasibility and preliminary results (1997) (0)
[Rationale for oncological surgery in multimodal cancer treatments]. (2005) (0)
[Surgical technics for implantation of hepatic intra-arterial catheters for local chemotherapy. Experience with 42 cases]. (1985) (0)
[Comment apropos of the article "Esophageal cancer: did combined treatment improve prognosis?" by G. Ganem et al]. (1993) (0)
Peritoneal carcinomatosis treatmnt with curative: Institut Gustave-Roussy experience (1997) (0)
[Reductional major surgery and chemotherapy in multimetastatic apudomas]. (1988) (0)
[The sentinel lymph node in carcinomas of the digestive tract]. (2002) (0)
[Colon and rectal tumours]. (2005) (0)
How to reduce the risk of recurrence after surgical treatment of colorectal liver metastases? (2011) (0)
[The new therapies of the peritoneal carcinomatosis should induce new surgical attitudes]. (2005) (0)
A prolonged follow-up provides new insights into locally advanced pancreatic cancer treatment. (2008) (0)
[New techniques and methods in the surgery of digestive cancers]. (2001) (0)
A phase I trial of intraperitoneal (IP) chemohyperthermia (CH) with oxaliplatin (L-OHP) and irinotecan (CPT-11) in patients (pts) with peritoneal carcinomatosis (PC): Pharmacokinetic (PK),tissue distribution and tolerance. (2004) (0)
PD-032Is there an impact of the number of metastases in the outcome of potentially resectable metastatic colorectal cancer patients receiving bevacizumab-based regimen in 1st line? Results of the PICASSO study (2016) (0)
Pseudocontinent perineal colostomy following abdominoperineal resection: Technique and findings in 40 patients (1997) (0)
[Chemotherapy of isolated hepatic metastases. Use of a subcutaneous reservoir for intra-arterial infusions]. (1984) (0)
Outcome of colorectal liver metastases vanishing under chemotherapy and finally missing after surgery. (2010) (0)
Iconography : Peritoneal carcinomatosis of colorectal origin (2008) (0)
Surgery and Tumors (2009) (0)
Which Intraarterial Hepatic Chemotherapy for Liver Metastasis from Colorectal Carcinoma?1 (1988) (0)
Results of curative strategy in patients with peritoneal and extraperitoneal metastases from colorectal cancer (2018) (0)
[Efficiency and reproducibility of an intraperitoneal chemo-hyperthermia technique after complete resection of peritoneal carcinoma]. (1999) (0)
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973) (2018) (0)
[Biodistribution of murine XF-8 monoclonal antibody in patients with colonic cancer]. (1991) (0)
[Nonresectable cancer of the rectum. 26 Cases treated by preoperative irradiation]. (1984) (0)
[Localized giant pseudo polyposis of the colon. Apropos of a case]. (1988) (0)
Retroperitoneal dissemination of colorectal ovarian metastases: Basis for rationale use of lymphadenectomy. (2011) (0)
Low anterior rectal resection by single port laparoscopy. (2013) (0)
[Early adjuvant intraportal chemotherapy after hepatectomy for metastases of colorectal origin]. (1986) (0)
Iconography : Surgical strategy for low rectal cancers (2014) (0)
A phase I trial of intraperitoneal (IP) chemohyperthermia (CH) with oxaliplatin (L-OHP) and irinotecan (CPT-11) in patients (pts) with peritoneal carcinomatosis (PC): Pharmacokinetic (PK),tissue distribution and tolerance (2004) (0)
[Combination vindesine, cyclophosphamide, cis-platinum and CCNU in esophageal epidermoid cancer. Preliminary analysis of 64 cases]. (1985) (0)
[Preoperative chemotherapy (neoadjuvant) of locally advanced gastric cancers]. (1993) (0)
Reply to M. Markman (2010) (0)
Iconography : A prolonged follow-up provides new insights into locally advanced pancreatic cancer treatment (2008) (0)
Selective Hepatic Intra-arterial Chemotherapy (2016) (0)
First-line (1-L) bevacizumab plus chemotherapy (Bev/CT) in colorectal cancer (CRC) patients with potentially resectable liver only (LM) or liver and lung metastases (LLM): KRAS mutation analysis of the non-interventional PICASSO study (2016) (0)
[Intermittent and ambulatory intra-arterial chemotherapy using a subcutaneous access chamber in the treatment of isolated hepatic metastases. Preliminary results]. (1985) (0)
Hepatic arterial infusion (HAI) of oxaliplatin with either LV5FU2 or FOLFIRI in patients (pts) with refractory metastatic colorectal cancer (mCRC). (2011) (0)
[Appendiceal tumors found at appendectomy]. (2009) (0)
Treatment (with a curative intent) of extrahepatic colorectal metastases (2007) (0)
Continuous infusion of 5-fluorouracil (5-FU) in neuroendocrine tumours (NET) (1999) (0)
[Positron emission tomography and gastrointestinal oncology]. (2003) (0)
[Intra-arterial hepatic chemotherapy. Experience of 200 cases]. (1994) (0)
[Locoregional chemotherapy of hepatic metastases of colorectal cancer]. (1987) (0)
The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without pre-operative chemotherapy [in revision] (2012) (0)
Hepatic arterial chemotherapy of 5 fluorouracil (5FU) combined with intravenous 5FU and folinic acid in patients with liver metastases of colorectal cancer (2001) (0)
Abstract 2797: Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine. (2013) (0)
[Verner-Morrison syndrome revealing a ganglioneuroblastoma in an adult]. (2008) (0)
43 Present and future of HIPEC (hyperthermic intraperitoneal chemotherapy) in colorectal carcinomatosis (2009) (0)
[Trauma of the ureters and of the urethra during rectal removal (author's transl)]. (1979) (0)
[Recent advances in digestive oncology (pancreas excluded)]. (2006) (0)
[Epidermoid cancer of the esophagus: is the combination of chemotherapy then surgery beneficial?]. (1989) (0)
238 ORAL Are extra-hepatic metastases still a contra-indication for hepatic colorectal metastases resection? (2006) (0)
[Locoregional chemotherapy of hepatic metastases]. (1985) (0)
[150 hepatic resections of malignant tumors. Technical aspects]. (1990) (0)
[Epidermoid cancer of the esophagus. Does the efficacy of chemoradiotherapy justify surgical abstention?]. (1989) (0)
586P Bidirectional chemotherapy for initially unresectable malignant peritoneal mesothelioma: Proof of concept of a new conversion strategy? (2020) (0)
Incidence and prognosis of synchronous colorectal (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dominique M. Elias?

Dominique M. Elias is affiliated with the following schools: